Annual Drug Patent Expirations for RESTASIS+MULTIDOSE
Restasis Multidose is a drug marketed by Allergan and is included in one NDA. It is available from two suppliers. There are ten patents protecting this drug.
RESTASIS MULTIDOSE drug price trends.
This drug has fifty patent family members in twenty-four countries.
The generic ingredient in RESTASIS MULTIDOSE is cyclosporine. Two suppliers are listed for this compound. Additional details are available on the cyclosporine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
